MEDVi tirzepatide review
Advertised at $399 and billed at $399 — no gap. Position 14 of 18 on our board.
Updated 2026-09-18
DISCLOSURE — Coreage Rx pays this desk a commission when a reader signs up through our link. It buys no ranking, no score and no deletions. Method: how we rate. Full terms: disclosure.
MEDVi publishes $399 a month for injections and holds it steady from month one — which is more than several competitors manage. The tablet price it does not publish at all.
Tablet pricing is quoted only after you complete the intake questionnaire, meaning health information changes hands before cost is disclosed. That is a choice, and worth knowing before you start filling in forms.
The numbers
| MEDVi · tirzepatide | |
|---|---|
| Advertised | $399/mo |
| Membership | None |
| Billed | $399/mo |
| Advertised-to-billed gap | None |
| Per year | $4,788 |
| Board position | 14 of 18, cheapest first |
Consistent month to month, but high.
Where the gap is
No intro-to-renewal step on the injection, which we will credit. The gap is disclosure: one of two products has no published price.
Against the board
About $4,788 a year, level with Willow and TrimRx’s billed rate, roughly double the top of the board.
| Programme | Advertised | Billed | Gap | Vs board floor |
|---|---|---|---|---|
| Coreage Rx | $149 | $199 | +$50 | +$74/mo |
| Trimi | $125 | $125 | none | — |
| Ozari Health | $125 | $125 | none | — |
| Fifty 410 | $133 | $133 | none | +$8/mo |
| PlexusDx | $129 | $189 | +$60 | +$64/mo |
| Ivím Health | $199 | $199 | none | +$74/mo |
| Zealthy | $216 | $216 | none | +$91/mo |
| Hims & Hers | $199 | $238 | +$39 | +$113/mo |
How the programme works
Compounded GLP-1 provider offering weekly injections and a tablet formulation, with tablet pricing quoted after intake rather than published.
Verified facts
- Compounded tirzepatide injections listed at $399/month.
- Tirzepatide tablet pricing is quoted after the intake questionnaire rather than published up front.
Checked 2026-09-18. This market re-prices without notice — anything older than a month is a starting point, not a quote.
For it
- Injection pricing is consistent between the first month and renewals.
- Tablet option for people who will not inject.
Against it
- Tablet pricing is withheld until after you have handed over health information.
- $399/month is roughly double the flat-rate leaders.
Read this bit. You have to complete intake before seeing tablet pricing. Injection pricing is published at $399.
Score
2.8 out of 5 on our rubric, which is fixed before assessment and published on how we rate.
| Criterion | Weight | Score |
|---|---|---|
| True monthly cost | 30% | 2.4 / 5 |
| Price honesty | 20% | 2.5 / 5 |
| Clinical support | 20% | 3.3 / 5 |
| Pharmacy sourcing | 15% | 3.2 / 5 |
| Cancelling | 15% | 3 / 5 |
Verdict
Consistent on the injection, opaque on the tablet, expensive on both. Get the tablet figure in writing before starting intake.
More from the desk
- Coreage Rx tirzepatide review
Advertised at $149, billed at $199. Position 1 of 18 on our board.
- Trimi tirzepatide review
Advertised at $125 and billed at $125 — no gap. Position 2 of 18 on our board.
- Ozari Health tirzepatide review
Advertised at $125 and billed at $125 — no gap. Position 3 of 18 on our board.
- Cheapest right now
Every programme sorted on what it bills, not what it advertises. Floor: $199/mo tirzepatide, $149/mo semaglutide.
- Six fee traps
Every advertised-to-billed gap on our board comes from one of these six structures. Learn them and you can read any of these sites in ninety seconds.
- Where the traps are
The biggest advertised-to-billed gaps on our board, and the programmes charging most for the same category of medication.